Cancer Larynx XTRA

Rife Frequencies for

Frequency Player

Volume: 50%
Waveform:

About This Program

Laryngeal cancer is a malignancy affecting the larynx, or voice box, a structure in the throat essential for breathing, swallowing, and speech. This condition can disrupt vocal function and overall quality of life, and conventional treatment typically involves oncology care tailored to the stage and location of the tumor. The Cancer Larynx XTRA program applies Rife frequency therapy as a complementary, non-invasive approach that targets the affected tissue with specific electromagnetic frequencies. Practitioners of frequency therapy believe that these frequencies may help create an unfavorable environment for abnormal cells, support the body's natural regulatory processes, reduce associated inflammation, and promote a sense of overall well-being during what can be a physically and emotionally demanding time. The XTRA designation indicates this program draws on an extended set of frequencies intended to broaden the therapeutic reach. Users exploring frequency therapy as a complement to their existing care plan may find it a gentle and accessible addition to their wellness routine. As with any supportive therapy, it is important to consult a qualified healthcare practitioner before beginning frequency sessions, particularly when managing a serious condition such as cancer.

Frequencies (4)

  • 327 Hz
  • 524 Hz
  • 731 Hz
  • 1133 Hz

Related Cancer Support Programs

View all Cancer Support programs →

Run all 4 Cancer Larynx XTRA frequencies at once

RifePlayer plays every Cancer Larynx XTRA frequency simultaneously — the fastest way to run a cancer support program, finishing in minutes instead of hours. Experience the full power of frequency therapy with our advanced multi-frequency technology.

⚡ Instant access • 🎯 All frequencies • ⏱️ Faster treatments

Ready to start your healing journey?

Experience the power of rife frequency therapy with RifePlayer - the easiest way to use rife frequencies for your wellness.